Treatment of side effects of motor and movement disorders associated with Parkinson's disease treatments

摘要

Eltoprazine or a pharmaceutically acceptable acid addition salt thereof for use in a method of preventing, attenuating and / or treating a side effect of a movement disorder or of a motor disorder associated with the administration of levodopa or a drug dopamine-related to an adult human patient presenting with Parkinson's disease; the method comprising administering eltoprazine or a pharmaceutically acceptable acid addition salt thereof to said adult human patient presenting with Parkinson's disease and in need of treatment in a dose range of 5 mg / day to 7.5 mg / day .